Reuters logo
BRIEF-Ligand announces licensing partner Janssen has filed an IND for an antibody discovered using the OmniAB Technology
March 28, 2017 / 1:46 PM / 7 months ago

BRIEF-Ligand announces licensing partner Janssen has filed an IND for an antibody discovered using the OmniAB Technology

March 28 (Reuters) - Ligand Pharmaceuticals Inc:

* Ligand announces licensing partner janssen has filed an IND for an antibody discovered using the OmniAB Technology

* Ligand Pharmaceuticals Inc - IND filing results in $1 million milestone payment to Ligand Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below